Biotechnology
The Biotechnology industry has a total of 594 stocks, with a combined market cap of $1.32 trillion and total revenue of $123.28 billion.
Market Cap
1.32T
Revenue
123.28B
Profits
-33.26B
PE Ratio
n/a
Profit Margin
-26.98%
Dividend Yield
0.04%
594 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 137.57B | -0.81% | 983,277 | 12.95B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 95.45B | -0.86% | 1,211,204 | 16.90B |
| 3 | MRNA | Moderna, Inc. | 93.61B | -6.97% | 7,010,789 | 2.53B |
| 4 | ARGX | argenx SE | 61.31B | 0.38% | 449,421 | 5.92B |
| 5 | ONC | BeOne Medicines AG | 47.51B | -0.96% | 342,707 | 6.45B |
| 6 | RPRX | Royalty Pharma plc | 39.56B | -1.49% | 3,784,306 | 2.62B |
| 7 | RVMD | Revolution Medicines, Inc. | 38.14B | -2.41% | 3,222,274 | 197.56M |
| 8 | GMAB | Genmab A/S | 31.75B | -3.95% | 5,627,904 | 4.30B |
| 9 | ROIV | Roivant Sciences Ltd. | 28.98B | -4.44% | 8,743,022 | 41.08M |
| 10 | INSM | Insmed Incorporated | 25.90B | -2.22% | 2,397,942 | 1.52B |
| 11 | INCY | Incyte Corporation | 24.81B | -0.47% | 1,008,914 | 6.01B |
| 12 | BNTX | BioNTech SE | 21.08B | -2.98% | 979,067 | 2.75B |
| 13 | ALNY | Alnylam Pharmaceuticals, Inc. | 20.98B | -2.00% | 3,516,222 | 5.01B |
| 14 | ASND | Ascendis Pharma A/S | 17.54B | 3.00% | 1,281,388 | 1.37B |
| 15 | EXEL | Exelixis, Inc. | 17.04B | -1.22% | 1,631,815 | 2.50B |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 15.43B | -3.17% | 584,263 | 4.72B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 15.23B | -1.72% | 1,804,089 | 945.54M |
| 18 | SMMT | Summit Therapeutics Inc. | 12.06B | -9.41% | 3,423,366 | - |
| 19 | HALO | Halozyme Therapeutics, Inc. | 11.48B | -0.99% | 1,430,954 | 1.80B |
| 20 | TECH | Bio-Techne Corporation | 11.44B | 0.05% | 2,183,574 | 1.23B |
| 21 | MTRI | Mentari Therapeutics, Inc. | 11.03B | 17.56% | 145,561 | - |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.98B | -2.79% | 1,941,427 | 3.66B |
| 23 | KYMR | Kymera Therapeutics, Inc. | 10.86B | -5.69% | 684,933 | 102.24M |
| 24 | PCVX | Vaxcyte, Inc. | 10.24B | -5.73% | 1,072,384 | - |
| 25 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.88B | -1.81% | 391,320 | 1.43B |
| 26 | SYRE | Spyre Therapeutics, Inc. | 9.77B | -3.66% | 985,299 | - |
| 27 | PRAX | Praxis Precision Medicines, Inc. | 9.08B | -6.20% | 590,074 | 7.46M |
| 28 | KRYS | Krystal Biotech, Inc. | 9.06B | -1.01% | 157,077 | 470.03M |
| 29 | TGTX | TG Therapeutics, Inc. | 9.04B | -1.82% | 1,579,114 | 897.76M |
| 30 | PTGX | Protagonist Therapeutics, Inc. | 8.77B | -0.36% | 542,887 | 551.69M |
| 31 | CORT | Corcept Therapeutics Incorporated | 8.07B | -1.10% | 847,070 | 963.65M |
| 32 | ABVX | ABIVAX Société Anonyme | 7.85B | -1.36% | 625,086 | 5.33M |
| 33 | CYTK | Cytokinetics, Incorporated | 7.82B | -4.05% | 2,008,944 | 113.29M |
| 34 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.62B | -2.05% | 1,064,819 | 280.75M |
| 35 | AXSM | Axsome Therapeutics, Inc. | 7.59B | -3.26% | 979,573 | 865.27M |
| 36 | IMVT | Immunovant, Inc. | 7.25B | -5.37% | 1,174,369 | - |
| 37 | TWST | Twist Bioscience Corporation | 7.16B | -6.83% | 5,291,741 | 459.43M |
| 38 | ORKA | Oruka Therapeutics, Inc. | 7.12B | -2.03% | 1,141,814 | - |
| 39 | CAI | Caris Life Sciences, Inc. | 6.87B | -2.16% | 3,571,693 | 1.05B |
| 40 | BLTE | Belite Bio, Inc | 6.84B | 8.99% | 496,174 | - |
| 41 | KOD | Kodiak Sciences Inc. | 6.79B | -1.00% | 557,841 | - |
| 42 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.66B | -4.48% | 1,731,696 | 450.82M |
| 43 | IBRX | ImmunityBio, Inc. | 6.46B | -9.00% | 21,017,851 | 182.57M |
| 44 | LGND | Ligand Pharmaceuticals Incorporated | 6.33B | -0.18% | 247,858 | 253.83M |
| 45 | CGON | CG Oncology, Inc. | 6.27B | -3.39% | 1,277,579 | 6.17M |
| 46 | MIRM | Mirum Pharmaceuticals, Inc. | 6.09B | -1.35% | 392,840 | 670.78M |
| 47 | MANE | Veradermics, Incorporated | 5.71B | -13.59% | 2,305,468 | - |
| 48 | ERAS | Erasca, Inc. | 5.52B | -6.07% | 4,857,093 | - |
| 49 | PTCT | PTC Therapeutics, Inc. | 5.29B | -2.39% | 538,665 | 1.16B |
| 50 | SRRK | Scholar Rock Holding Corporation | 5.27B | -7.38% | 1,378,351 | 570.00K |
| 51 | DNTH | Dianthus Therapeutics, Inc. | 5.21B | 3.56% | 921,000 | 2.72M |
| 52 | COGT | Cogent Biosciences, Inc. | 5.07B | -0.88% | 1,858,718 | - |
| 53 | EWTX | Edgewise Therapeutics, Inc. | 5.02B | -3.68% | 1,097,354 | - |
| 54 | TVTX | Travere Therapeutics, Inc. | 4.95B | -0.92% | 589,597 | 651.03M |
| 55 | IONS | Ionis Pharmaceuticals, Inc. | 4.55B | -3.60% | 6,200,023 | 960.09M |
| 56 | DFTX | Definium Therapeutics, Inc. | 4.52B | -4.26% | 1,202,591 | - |
| 57 | TNGX | Tango Therapeutics, Inc. | 4.21B | -3.42% | 3,485,268 | 53.81M |
| 58 | CRSP | CRISPR Therapeutics AG | 4.13B | -6.84% | 2,492,518 | 25.17M |
| 59 | XENE | Xenon Pharmaceuticals Inc. | 4.03B | -2.62% | 1,207,166 | 7.50M |
| 60 | RLAY | Relay Therapeutics, Inc. | 3.99B | -8.32% | 2,768,503 | 10.35M |
| 61 | TARS | Tarsus Pharmaceuticals, Inc. | 3.79B | 0.17% | 445,018 | 682.20M |
| 62 | IRON | Disc Medicine, Inc. | 3.79B | -4.42% | 761,213 | - |
| 63 | ABCL | AbCellera Biologics Inc. | 3.77B | -2.76% | 3,154,952 | 67.85M |
| 64 | LEGN | Legend Biotech Corporation | 3.60B | -5.12% | 4,449,279 | 1.36B |
| 65 | ELVN | Enliven Therapeutics, Inc. | 3.56B | -5.63% | 917,120 | - |
| 66 | IOVA | Iovance Biotherapeutics, Inc. | 3.53B | -5.69% | 10,386,896 | 378.98M |
| 67 | VKTX | Viking Therapeutics, Inc. | 3.52B | -3.02% | 2,185,711 | - |
| 68 | ARQT | Arcutis Biotherapeutics, Inc. | 3.48B | -3.00% | 1,894,593 | 508.68M |
| 69 | VRDN | Viridian Therapeutics, Inc. | 3.46B | -2.46% | 1,948,671 | 26.31M |
| 70 | PBLS | Parabilis Medicines, Inc. | 3.42B | -6.61% | 806,101 | 2.26M |
| 71 | DYN | Dyne Therapeutics, Inc. | 3.19B | -5.45% | 2,311,962 | - |
| 72 | TLX | Telix Pharmaceuticals Limited | 3.17B | -3.75% | 250,969 | 890.79M |
| 73 | CELC | Celcuity Inc. | 3.15B | -0.23% | 906,767 | - |
| 74 | ACAD | Acadia Pharmaceuticals Inc. | 3.14B | -1.25% | 1,934,196 | 1.20B |
| 75 | IDYA | IDEAYA Biosciences, Inc. | 3.04B | -3.74% | 615,893 | 36.54M |
| 76 | DNLI | Denali Therapeutics Inc. | 3.03B | -4.26% | 1,309,620 | 21.38M |
| 77 | ADMA | ADMA Biologics, Inc. | 2.94B | 0.38% | 3,091,047 | 519.15M |
| 78 | VCEL | Vericel Corporation | 2.93B | -3.41% | 826,406 | 324.17M |
| 79 | ZLAB | Zai Lab Limited | 2.93B | -1.44% | 857,995 | 441.73M |
| 80 | XNCR | Xencor, Inc. | 2.86B | -4.60% | 1,177,254 | 200.49M |
| 81 | MBX | MBX Biosciences, Inc. | 2.71B | -5.56% | 321,980 | - |
| 82 | RCUS | Arcus Biosciences, Inc. | 2.56B | -5.48% | 1,097,932 | 100.00M |
| 83 | BEAM | Beam Therapeutics Inc. | 2.40B | -6.90% | 1,511,747 | 146.64M |
| 84 | NAMS | NewAmsterdam Pharma Company N.V. | 2.40B | -3.62% | 2,278,848 | 25.94M |
| 85 | PHVS | Pharvaris N.V. | 2.38B | -1.02% | 376,267 | - |
| 86 | CLDX | Celldex Therapeutics, Inc. | 2.24B | -5.37% | 867,084 | 158.00K |
| 87 | PVLA | Palvella Therapeutics, Inc. | 2.24B | -6.56% | 282,678 | - |
| 88 | IMNM | Immunome, Inc. | 2.21B | -1.94% | 1,658,580 | 4.02M |
| 89 | LKFT | Lakefront Biotherapeutics NV | 2.20B | 1.77% | 535,512 | 1.13B |
| 90 | AUPH | Aurinia Pharmaceuticals Inc. | 2.17B | 0.00% | 625,056 | 321.74M |
| 91 | BHVN | Biohaven Ltd. | 2.13B | -7.37% | 1,629,385 | - |
| 92 | VERA | Vera Therapeutics, Inc. | 2.10B | -4.72% | 763,321 | 10.28M |
| 93 | REPL | Replimune Group, Inc. | 2.08B | 0.92% | 2,497,944 | - |
| 94 | RXRX | Recursion Pharmaceuticals, Inc. | 2.08B | -7.24% | 18,791,545 | 68.23M |
| 95 | VIR | Vir Biotechnology, Inc. | 2.08B | -7.69% | 1,460,058 | 302.80M |
| 96 | TRAX | First Tracks Biotherapeutics, Inc. | 2.05B | -3.62% | 310,808 | - |
| 97 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.00B | -0.26% | 2,504,476 | 213.00M |
| 98 | SEPN | Septerna, Inc. | 1.99B | -13.80% | 608,540 | 96.27M |
| 99 | HRMY | Harmony Biosciences Holdings, Inc. | 1.98B | -1.23% | 936,219 | 989.36M |
| 100 | MAZE | Maze Therapeutics, Inc. | 1.97B | -1.74% | 451,365 | 20.00M |
| 101 | TRVI | Trevi Therapeutics, Inc. | 1.94B | -8.07% | 2,011,127 | - |
| 102 | FTRE | Fortrea Holdings Inc. | 1.94B | -1.57% | 1,594,385 | 2.67B |
| 103 | AGIO | Agios Pharmaceuticals, Inc. | 1.90B | -3.23% | 497,026 | 140.84M |
| 104 | LYCA | Lycia Therapeutics, Inc. | 1.89B | 4.42% | 496,078 | 4.44M |
| 105 | ZBIO | Zenas BioPharma, Inc. | 1.87B | -3.69% | 857,030 | 11.00M |
| 106 | COAG | Hemab Therapeutics Holdings, Inc. | 1.84B | 0.13% | 426,189 | - |
| 107 | ZYME | Zymeworks Inc. | 1.83B | -8.94% | 1,331,315 | 265.97M |
| 108 | QURE | uniQure N.V. | 1.73B | 0.18% | 2,133,166 | 20.17M |
| 109 | SRPT | Sarepta Therapeutics, Inc. | 1.72B | -4.02% | 2,209,659 | 1.96B |
| 110 | KLRA | Kailera Therapeutics, Inc. | 1.72B | -8.14% | 563,116 | - |
| 111 | STOK | Stoke Therapeutics, Inc. | 1.71B | -5.62% | 500,788 | 28.21M |
| 112 | NRIX | Nurix Therapeutics, Inc. | 1.70B | -4.47% | 1,338,381 | 701.94M |
| 113 | BRVE | Braveheart Bio, Inc. | 1.67B | -1.91% | 256,070 | - |
| 114 | PGEN | Precigen, Inc. | 1.67B | -1.27% | 5,317,987 | 156.94M |
| 115 | ADRX | ADARx Pharmaceuticals, Inc. | 1.67B | 12.11% | 994,874 | 6.13M |
| 116 | MESO | Mesoblast Limited | 1.66B | -4.03% | 184,222 | 120.25M |
| 117 | RARE | Ultragenyx Pharmaceutical Inc. | 1.65B | -2.57% | 3,617,062 | 730.00M |
| 118 | SLS | SELLAS Life Sciences Group, Inc. | 1.62B | -4.63% | 4,349,046 | - |
| 119 | GENB | Generate Biomedicines, Inc. | 1.61B | -6.82% | 1,608,132 | 21.07M |
| 120 | NBTX | Nanobiotix S.A. | 1.60B | -2.12% | 171,115 | 13.15M |
| 121 | IMCR | Immunocore Holdings plc | 1.57B | -3.71% | 460,900 | 429.30M |
| 122 | ABSI | Absci Corporation | 1.57B | -9.73% | 4,918,252 | 1.49M |
| 123 | RAPP | Rapport Therapeutics, Inc. | 1.53B | -4.33% | 568,337 | 20.00M |
| 124 | NTLA | Intellia Therapeutics, Inc. | 1.48B | -7.54% | 3,624,981 | 52.89M |
| 125 | NVAX | Novavax, Inc. | 1.45B | -12.22% | 6,410,176 | 411.65M |
| 126 | NUVB | Nuvation Bio Inc. | 1.43B | -5.36% | 5,150,871 | 201.73M |
| 127 | ANAB | AnaptysBio, Inc. | 1.43B | -2.05% | 262,892 | 60.04M |
| 128 | KRSA | Korsana Biosciences, Inc. | 1.42B | -1.76% | 167,582 | - |
| 129 | GPCR | Structure Therapeutics Inc. | 1.41B | -5.30% | 1,062,647 | - |
| 130 | OCUL | Ocular Therapeutix, Inc. | 1.38B | -5.71% | 2,337,157 | 50.38M |
| 131 | LBRX | LB Pharmaceuticals Inc | 1.37B | -5.03% | 439,161 | - |
| 132 | MLYS | Mineralys Therapeutics, Inc. | 1.37B | -4.08% | 2,929,501 | - |
| 133 | TSHA | Taysha Gene Therapies, Inc. | 1.37B | -1.64% | 3,878,457 | 5.49M |
| 134 | AAPG | Ascentage Pharma Group International | 1.37B | 0.13% | 2,433 | 94.61M |
| 135 | TYRA | Tyra Biosciences, Inc. | 1.37B | -5.75% | 854,510 | - |
| 136 | DMRA | Damora Therapeutics, Inc. | 1.36B | -5.16% | 670,991 | - |
| 137 | AVLN | Avalyn Pharma Inc. | 1.36B | -3.26% | 499,880 | - |
| 138 | INVA | Innoviva, Inc. | 1.35B | 0.58% | 563,819 | 438.32M |
| 139 | MNKD | MannKind Corporation | 1.34B | -0.72% | 3,504,825 | 413.37M |
| 140 | KARD | Kardigan, Inc. | 1.32B | -9.95% | 345,772 | - |
| 141 | OMER | Omeros Corporation | 1.30B | -0.88% | 809,958 | 38.42M |
| 142 | URGN | UroGen Pharma Ltd. | 1.29B | 1.11% | 970,065 | 250.25M |
| 143 | INBX | Inhibrx Biosciences, Inc. | 1.29B | -3.14% | 226,475 | 1.30M |
| 144 | NKTR | Nektar Therapeutics | 1.27B | -3.10% | 775,137 | 52.19M |
| 145 | SVRA | Savara Inc. | 1.27B | -5.41% | 3,885,068 | - |
| 146 | GHRS | GH Research PLC | 1.27B | -3.95% | 191,830 | - |
| 147 | DRTS | Alpha Tau Medical Ltd. | 1.23B | -4.71% | 612,799 | - |
| 148 | SLN | Silence Therapeutics plc | 1.23B | 0.15% | 659,203 | 615.00K |
| 149 | ANRO | Alto Neuroscience, Inc. | 1.23B | -1.70% | 1,288,568 | - |
| 150 | VOR | Vor Biopharma Inc. | 1.19B | -3.83% | 796,341 | - |
| 151 | SGP | SpyGlass Pharma, Inc. | 1.11B | -4.72% | 54,414 | - |
| 152 | MLTX | MoonLake Immunotherapeutics | 1.10B | -4.74% | 1,519,245 | - |
| 153 | SPTX | Seaport Therapeutics, Inc. | 1.08B | -5.54% | 228,588 | - |
| 154 | VSTM | Verastem, Inc. | 1.06B | -7.15% | 2,085,610 | 100.30M |
| 155 | JBIO | Jade Biosciences, Inc. | 1.01B | -4.05% | 880,375 | - |
| 156 | ODTX | Odyssey Therapeutics, Inc. | 963.62M | -4.24% | 321,962 | 99.00K |
| 157 | CTY | City Therapeutics, Inc. | 944.38M | 11.58% | 216,893 | 14.34M |
| 158 | IVA | Inventiva S.A. | 906.34M | -3.24% | 2,503,711 | 2.81M |
| 159 | AKTS | Aktis Oncology, Inc. | 905.49M | -4.46% | 245,499 | 12.39M |
| 160 | CRVS | Corvus Pharmaceuticals, Inc. | 895.83M | -7.41% | 1,021,016 | - |
| 161 | IMTX | Immatics N.V. | 891.22M | -2.54% | 809,266 | 49.33M |
| 162 | ORIC | ORIC Pharmaceuticals, Inc. | 881.05M | -5.56% | 1,178,644 | - |
| 163 | PHAR | Pharming Group N.V. | 878.56M | -3.36% | 12,636 | 386.75M |
| 164 | RIGL | Rigel Pharmaceuticals, Inc. | 860.34M | 2.63% | 325,687 | 288.21M |
| 165 | MGTX | MeiraGTx Holdings plc | 859.05M | -9.19% | 1,363,121 | 401.91M |
| 166 | SNDX | Syndax Pharmaceuticals, Inc. | 858.87M | -0.52% | 2,830,157 | 289.68M |
| 167 | LTGO | Latigo Biotherapeutics, Inc. | 857.25M | -4.36% | 167,664 | - |
| 168 | BBTX | Bambusa Therapeutics, Inc. | 853.29M | -2.39% | 94,800 | - |
| 169 | LXRX | Lexicon Pharmaceuticals, Inc. | 810.33M | -2.67% | 1,685,639 | 38.54M |
| 170 | GLUE | Monte Rosa Therapeutics, Inc. | 795.54M | -9.70% | 1,245,710 | 70.33M |
| 171 | ALMS | Alumis Inc. | 793.44M | -7.40% | 1,864,085 | 7.40M |
| 172 | ARDX | Ardelyx, Inc. | 784.28M | -0.32% | 4,034,282 | 468.22M |
| 173 | SLDB | Solid Biosciences Inc. | 781.27M | -7.89% | 1,314,460 | - |
| 174 | SGMT | Sagimet Biosciences Inc. | 775.03M | -4.21% | 1,441,415 | - |
| 175 | OBX | Obsidian Therapeutics, Inc. | 770.93M | -3.11% | 328,720 | - |
| 176 | ANNX | Annexon, Inc. | 757.33M | -5.25% | 4,463,379 | - |
| 177 | AURA | Aura Biosciences, Inc. | 739.97M | -6.57% | 1,006,708 | - |
| 178 | OABI | OmniAb, Inc. | 722.01M | -2.94% | 1,403,467 | 40.21M |
| 179 | ATTO | Attovia Therapeutics, Inc. | 721.75M | -5.50% | 222,107 | 1.44M |
| 180 | DBVT | DBV Technologies S.A. | 708.70M | -3.79% | 337,294 | 3.74M |
| 181 | IAM | Iambic Therapeutics, Inc. | 703.43M | -3.54% | 490,428 | 18.25M |
| 182 | JANX | Janux Therapeutics, Inc. | 703.30M | -7.22% | 1,169,152 | 23.29M |
| 183 | NVCT | Nuvectis Pharma, Inc. | 695.69M | -3.67% | 206,530 | - |
| 184 | APMD | Apnimed, Inc. | 692.32M | -0.89% | 278,709 | 115.12M |
| 185 | PRME | Prime Medicine, Inc. | 692.05M | -9.53% | 7,172,636 | 7.06M |
| 186 | KURA | Kura Oncology, Inc. | 682.66M | -3.88% | 2,844,560 | 79.31M |
| 187 | DSGN | Design Therapeutics, Inc. | 677.50M | -1.76% | 502,503 | - |
| 188 | ANL | Adlai Nortye Group Ltd. | 677.47M | -3.04% | 130,644 | 18.06M |
| 189 | AVBP | ArriVent BioPharma, Inc. | 676.02M | -3.22% | 793,880 | 5.00M |
| 190 | BCAX | Bicara Therapeutics Inc. | 671.17M | -3.99% | 1,891,506 | - |
| 191 | FDMT | 4D Molecular Therapeutics, Inc. | 669.28M | -6.74% | 897,223 | 96.06M |
| 192 | IMMX | Immix Biopharma, Inc. | 669.03M | -6.81% | 959,606 | - |
| 193 | ZVRA | Zevra Therapeutics, Inc. | 664.07M | -5.82% | 822,737 | 147.76M |
| 194 | DNA | Ginkgo Bioworks Holdings, Inc. | 663.08M | -0.20% | 2,497,107 | 130.75M |
| 195 | CGEM | Cullinan Therapeutics, Inc. | 661.54M | -10.22% | 1,135,459 | - |
| 196 | OLMA | Olema Pharmaceuticals, Inc. | 658.80M | -6.47% | 1,996,916 | - |
| 197 | HELP | Helus Pharma Inc. | 647.31M | -5.64% | 1,116,608 | - |
| 198 | CADL | Candel Therapeutics, Inc. | 641.99M | -9.00% | 1,905,733 | - |
| 199 | GERN | Geron Corporation | 640.37M | -2.55% | 10,353,648 | 217.52M |
| 200 | CLYM | Climb Bio, Inc. | 638.48M | -11.27% | 1,346,255 | - |
| 201 | ACRS | Aclaris Therapeutics, Inc. | 634.45M | -7.83% | 1,956,661 | 6.40M |
| 202 | WVE | Wave Life Sciences, Inc. | 622.26M | -7.75% | 2,470,700 | 70.92M |
| 203 | ABUS | Arbutus Biopharma Corporation | 617.77M | 3.87% | 3,954,497 | 181.49M |
| 204 | CBIO | Crescent Biopharma, Inc. | 615.05M | -2.61% | 209,892 | 15.00M |
| 205 | SRZN | Surrozen, Inc. | 603.68M | -0.66% | 133,843 | 10.53M |
| 206 | SANA | Sana Biotechnology, Inc. | 602.27M | -12.23% | 3,244,494 | - |
| 207 | CAPR | Capricor Therapeutics, Inc. | 595.38M | -8.73% | 4,753,787 | 11.13M |
| 208 | ETRA | Electra Therapeutics, Inc. | 571.81M | -3.60% | 545,248 | - |
| 209 | ENTX | Entera Bio Ltd. | 560.72M | 0.00% | 170,481 | 42.00K |
| 210 | VALN | Valneva SE | 553.74M | -2.70% | 5,549 | 163.30M |
| 211 | RGNX | REGENXBIO Inc. | 530.96M | -5.19% | 1,286,210 | 153.91M |
| 212 | EPRX | Eupraxia Pharmaceuticals Inc. | 513.45M | -3.10% | 398,347 | - |
| 213 | DMAC | DiaMedica Therapeutics Inc. | 503.13M | -3.42% | 187,770 | - |
| 214 | PHAT | Phathom Pharmaceuticals, Inc. | 494.85M | -0.80% | 1,087,514 | 274.88M |
| 215 | NGNE | Neurogene Inc. | 494.75M | -4.78% | 237,849 | 925.00K |
| 216 | STTK | Shattuck Labs, Inc. | 489.86M | -4.75% | 1,320,324 | 1.00M |
| 217 | MNPR | Monopar Therapeutics Inc. | 487.84M | 1.32% | 313,016 | - |
| 218 | OBIO | Orchestra BioMed Holdings, Inc. | 484.04M | 2.33% | 631,014 | 31.21M |
| 219 | INDP | Indaptus Therapeutics, Inc. | 483.78M | -1.87% | 118,325 | - |
| 220 | OVID | Ovid Therapeutics Inc. | 481.27M | -8.27% | 2,924,923 | 1.45M |
| 221 | MDXG | MiMedx Group, Inc. | 472.80M | -2.41% | 1,474,681 | 303.73M |
| 222 | BLSM | BlossomHill Therapeutics, Inc. | 471.69M | -7.94% | 256,382 | - |
| 223 | GYRE | Gyre Therapeutics, Inc. | 470.64M | 0.94% | 173,993 | 110.06M |
| 224 | OCS | Oculis Holding AG | 462.99M | -1.45% | 299,097 | 1.12M |
| 225 | ARVN | Arvinas, Inc. | 449.88M | -0.58% | 923,733 | 275.30M |
| 226 | AVTX | Avalo Therapeutics, Inc. | 445.24M | -9.52% | 2,960,481 | 59.00K |
| 227 | CTMX | CytomX Therapeutics, Inc. | 444.73M | -4.23% | 3,156,537 | 14.03M |
| 228 | RLMD | Relmada Therapeutics, Inc. | 443.75M | -6.09% | 1,038,496 | - |
| 229 | SLBT | SL Science Holding Limited | 435.85M | 5.80% | 26,692 | 3.27M |
| 230 | PRTA | Prothena Corporation plc | 422.61M | -5.73% | 237,009 | 52.74M |
| 231 | PBYI | Puma Biotechnology, Inc. | 417.72M | 0.00% | 448,733 | 231.83M |
| 232 | TECX | Tectonic Therapeutic, Inc. | 411.32M | -4.19% | 121,724 | - |
| 233 | ASMB | Assembly Biosciences, Inc. | 410.88M | -9.79% | 498,746 | 67.01M |
| 234 | RZLT | Rezolute, Inc. | 405.98M | -4.91% | 1,089,286 | - |
| 235 | ASPE | Aspen Neuroscience, Inc. | 395.76M | -1.52% | 267,365 | - |
| 236 | MPLT | MapLight Therapeutics, Inc. | 392.92M | -5.48% | 266,219 | - |
| 237 | IRD | Opus Genetics, Inc. | 392.42M | -5.80% | 1,387,997 | 7.91M |
| 238 | LYEL | Lyell Immunopharma, Inc. | 384.52M | -7.24% | 130,954 | 15.00K |
| 239 | CTNM | Contineum Therapeutics, Inc. | 384.02M | -9.19% | 315,423 | - |
| 240 | SPRY | ARS Pharmaceuticals, Inc. | 383.01M | -3.54% | 2,289,034 | 122.14M |
| 241 | FENC | Fennec Pharmaceuticals Inc. | 382.23M | 2.44% | 284,812 | 66.37M |
| 242 | TRXB | TRex Bio, Inc. | 379.60M | -1.05% | 45,615 | - |
| 243 | CRMD | CorMedix Inc. | 377.25M | -8.68% | 3,681,347 | 412.49M |
| 244 | YDES | YD Bio Limited | 367.97M | -15.53% | 78,296 | 1.24M |
| 245 | ALEC | Alector, Inc. | 364.75M | -6.84% | 1,871,471 | 173.47M |
| 246 | CCCC | C4 Therapeutics, Inc. | 363.75M | -4.15% | 4,966,866 | 32.28M |
| 247 | PRLD | Prelude Therapeutics Incorporated | 362.54M | -6.88% | 230,863 | 22.42M |
| 248 | PEPG | PepGen Inc. | 349.07M | -4.18% | 12,094,633 | - |
| 249 | PROK | ProKidney Corp. | 347.67M | 1.77% | 1,086,887 | 818.00K |
| 250 | AVIR | Atea Pharmaceuticals, Inc. | 338.08M | -0.24% | 244,197 | - |
| 251 | EDIT | Editas Medicine, Inc. | 330.29M | -10.08% | 3,886,850 | 49.83M |
| 252 | EIKN | Eikon Therapeutics, Inc. | 327.16M | -9.45% | 735,487 | - |
| 253 | ENTA | Enanta Pharmaceuticals, Inc. | 326.20M | -3.45% | 256,147 | 65.26M |
| 254 | XFOR | X4 Pharmaceuticals, Inc. | 323.70M | -1.86% | 2,163,977 | 16.96M |
| 255 | SCTX | Scribe Therapeutics Inc. | 321.65M | 0.77% | 282,268 | 33.30M |
| 256 | BNTC | Benitec Biopharma Inc. | 317.08M | -4.01% | 231,626 | - |
| 257 | AUTL | Autolus Therapeutics plc | 316.73M | -3.64% | 2,573,187 | 137.43M |
| 258 | GALT | Galectin Therapeutics Inc. | 316.67M | -4.56% | 226,410 | - |
| 259 | AGMB | AgomAb Therapeutics NV | 313.22M | -9.01% | 1,517,921 | - |
| 260 | ALT | Altimmune, Inc. | 313.17M | -16.58% | 12,453,991 | 26.00K |
| 261 | KYTX | Kyverna Therapeutics, Inc. | 311.07M | -1.76% | 1,201,851 | - |
| 262 | AGEN | Agenus Inc. | 310.84M | -4.85% | 498,828 | 133.95M |
| 263 | VCRE | Vicore Pharma Holding AB (publ) | 308.52M | -2.83% | 5,517 | 383.48K |
| 264 | IKT | Inhibikase Therapeutics, Inc. | 307.28M | -6.13% | 727,020 | 1.00 |
| 265 | DTIL | Precision BioSciences, Inc. | 306.89M | -12.13% | 414,401 | 45.04M |
| 266 | NAUT | Nautilus Biotechnology, Inc. | 303.15M | -1.65% | 3,318,309 | 424.00K |
| 267 | TTRX | Turn Therapeutics Inc. | 301.75M | -4.16% | 98,764 | - |
| 268 | OCGN | Ocugen, Inc. | 296.42M | -9.04% | 5,642,426 | 4.78M |
| 269 | IPSC | Century Therapeutics, Inc. | 295.15M | -6.32% | 608,755 | 109.16M |
| 270 | EVMN | Evommune, Inc. | 291.06M | -6.96% | 1,116,197 | 10.00M |
| 271 | CABA | Cabaletta Bio, Inc. | 286.91M | -8.28% | 3,733,076 | - |
| 272 | ALLO | Allogene Therapeutics, Inc. | 286.53M | -8.12% | 10,662,541 | 4.64M |
| 273 | VOGX | Vogenx, Inc. | 284.47M | -7.80% | 104,449 | - |
| 274 | LRMR | Larimar Therapeutics, Inc. | 281.83M | -1.10% | 1,212,013 | - |
| 275 | FULC | Fulcrum Therapeutics, Inc. | 280.77M | -1.60% | 2,139,186 | 80.00M |
| 276 | SABS | SAB Biotherapeutics, Inc. | 277.47M | -0.96% | 2,111,523 | 114.70K |
| 277 | FTH | Faeth Therapeutics, Inc. | 275.20M | -20.22% | 766,859 | - |
| 278 | QTTB | Q32 Bio Inc. | 263.93M | -4.13% | 355,589 | 53.74M |
| 279 | RCKT | Rocket Pharmaceuticals, Inc. | 262.36M | -3.63% | 955,292 | - |
| 280 | INO | Inovio Pharmaceuticals, Inc. | 262.28M | -1.02% | 7,895,276 | 298.90K |
| 281 | CUVL | Clinuvel Pharmaceuticals Limited | 260.29M | -0.79% | 6,722 | 65.05M |
| 282 | VTVT | vTv Therapeutics Inc. | 257.07M | -3.63% | 9,205 | 36.84M |
| 283 | CAMP | Camp4 Therapeutics Corporation | 256.66M | -2.62% | 62,317 | 5.32M |
| 284 | LCTX | Lineage Cell Therapeutics, Inc. | 250.45M | -10.78% | 1,376,711 | 10.84M |
| 285 | PLX | Protalix BioTherapeutics, Inc. | 249.58M | -5.43% | 2,436,756 | 84.69M |
| 286 | ARCT | Arcturus Therapeutics Holdings Inc. | 243.26M | -9.34% | 430,293 | 30.51M |
| 287 | BCYC | Bicycle Therapeutics plc | 241.82M | -6.50% | 630,100 | 83.53M |
| 288 | VNDA | Vanda Pharmaceuticals Inc. | 238.86M | -4.82% | 1,240,847 | 229.28M |
| 289 | LXEO | Lexeo Therapeutics, Inc. | 238.74M | -5.21% | 1,717,408 | - |
| 290 | IMRX | Immuneering Corporation | 237.68M | -3.17% | 479,949 | - |
| 291 | GLSI | Greenwich LifeSciences, Inc. | 224.28M | -5.03% | 206,939 | - |
| 292 | ACIU | AC Immune SA | 212.77M | -5.31% | 121,753 | 23.75M |
| 293 | PALI | Palisade Bio, Inc. | 204.38M | -2.56% | 985,370 | 500.00K |
| 294 | CGEN | Compugen Ltd. | 200.82M | 1.44% | 190,239 | 75.93M |
| 295 | KROS | Keros Therapeutics, Inc. | 197.81M | 5.66% | 630,066 | 40.76M |
| 296 | KRRO | Korro Bio, Inc. | 196.41M | -0.69% | 203,156 | 1.29M |
| 297 | ARTV | Artiva Biotherapeutics, Inc. | 195.75M | -2.70% | 1,436,864 | 251.00K |
| 298 | RNAC | Cartesian Therapeutics, Inc. | 193.85M | -7.63% | 264,896 | 1.03M |
| 299 | ELDN | Eledon Pharmaceuticals, Inc. | 192.37M | -11.42% | 812,065 | - |
| 300 | PRQR | ProQR Therapeutics N.V. | 191.93M | 7.94% | 814,529 | 21.05M |
| 301 | TRDA | Entrada Therapeutics, Inc. | 188.74M | -4.96% | 808,438 | 3.98M |
| 302 | PYXS | Pyxis Oncology, Inc. | 188.74M | -3.66% | 1,003,370 | 11.04M |
| 303 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 188.41M | -8.20% | 778,936 | - |
| 304 | ACOG | Alpha Cognition Inc. | 186.42M | -0.70% | 139,196 | 20.20M |
| 305 | MDWD | MediWound Ltd. | 185.34M | -6.15% | 354,543 | 10.01M |
| 306 | SLGL | Sol-Gel Technologies Ltd. | 184.16M | -11.28% | 44,832 | 1.80M |
| 307 | IFRX | InflaRx N.V. | 182.74M | 5.08% | 883,017 | -38.53K |
| 308 | YARW | Yarrow Bioscience, Inc. | 182.64M | 8.75% | 134,597 | - |
| 309 | WHWK | Whitehawk Therapeutics, Inc. | 181.16M | -5.25% | 342,176 | 7.15M |
| 310 | NGEN | NervGen Pharma Corp. | 175.26M | 20.74% | 2,518,684 | - |
| 311 | DRUG | Bright Minds Biosciences Inc. | 172.88M | -3.03% | 119,866 | - |
| 312 | ANTX | AN2 Therapeutics, Inc. | 168.47M | -0.45% | 186,344 | - |
| 313 | ORMP | Oramed Pharmaceuticals Inc. | 167.64M | -2.42% | 112,336 | 2.00M |
| 314 | IVVD | Invivyd, Inc. | 167.22M | -5.34% | 2,623,598 | 58.37M |
| 315 | HUMA | Humacyte, Inc. | 165.40M | 0.63% | 5,113,499 | 2.40M |
| 316 | ZNTL | Zentalis Pharmaceuticals, Inc. | 165.09M | -11.11% | 1,621,655 | 26.87M |
| 317 | VRXA | Veraxa Biotech AG | 162.62M | -8.73% | 105,836 | 29.54K |
| 318 | FATE | Fate Therapeutics, Inc. | 160.56M | -16.51% | 3,687,790 | 4.75M |
| 319 | STRO | Sutro Biopharma, Inc. | 159.01M | -6.53% | 656,926 | 45.70M |
| 320 | UPB | Upstream Bio, Inc. | 156.76M | -10.63% | 2,527,498 | 2.87M |
| 321 | SION | Sionna Therapeutics, Inc. | 155.16M | -7.30% | 411,786 | - |
| 322 | ENGN | enGene Therapeutics Inc. | 152.80M | 26.67% | 11,705,452 | - |
| 323 | TARA | Protara Therapeutics, Inc. | 150.23M | -6.87% | 1,135,016 | - |
| 324 | ALXO | ALX Oncology Holdings Inc. | 149.34M | -3.57% | 1,530,861 | - |
| 325 | CMPX | Compass Therapeutics, Inc. | 147.67M | -1.23% | 1,842,934 | 850.00K |
| 326 | MGNX | MacroGenics, Inc. | 145.87M | -1.29% | 894,628 | 120.97M |
| 327 | CNTN | Canton Strategic Holdings, Inc. | 143.43M | -7.69% | 931,575 | 1.50M |
| 328 | MSLE | Satellos Bioscience Inc. | 142.41M | 1.19% | 55,939 | - |
| 329 | ARMP | Armata Pharmaceuticals, Inc. | 138.32M | -4.37% | 105,067 | 5.54M |
| 330 | ADAG | Adagene Inc. | 134.29M | -6.10% | 278,107 | 9.29M |
| 331 | ABEO | Abeona Therapeutics Inc. | 130.87M | -0.43% | 2,416,845 | 39.01M |
| 332 | PYPD | PolyPid Ltd. | 130.00M | -3.03% | 188,217 | - |
| 333 | IPHA | Innate Pharma S.A. | 128.75M | -6.29% | 19,176 | 11.21M |
| 334 | LENZ | LENZ Therapeutics, Inc. | 128.51M | -0.49% | 773,006 | 12.36M |
| 335 | RNA | Atrium Therapeutics, Inc. | 128.29M | -5.78% | 294,715 | 35.84M |
| 336 | CUE | Cue Biopharma, Inc. | 127.13M | -6.22% | 147,416 | 37.66M |
| 337 | MENS | Jyong Biotech Ltd. | 124.71M | -3.45% | 20,098 | - |
| 338 | SPRB | Spruce Biosciences, Inc. | 123.27M | -7.16% | 45,985 | 697.00K |
| 339 | FHTX | Foghorn Therapeutics Inc. | 122.92M | -1.91% | 579,935 | 112.13M |
| 340 | OKUR | OnKure Therapeutics, Inc. | 121.91M | -10.42% | 286,825 | - |
| 341 | NTHI | NeOnc Technologies Holdings, Inc. | 120.56M | 7.30% | 315,604 | 39.99K |
| 342 | ZURA | Zura Bio Limited | 119.44M | -13.29% | 3,385,001 | - |
| 343 | NERV | Minerva Neurosciences, Inc. | 118.61M | -7.03% | 79,393 | - |
| 344 | MOLN | Molecular Partners AG | 110.95M | -2.59% | 693 | 856.30K |
| 345 | OTLK | Outlook Therapeutics, Inc. | 107.14M | -8.50% | 2,444,541 | -1.16M |
| 346 | IMUX | Immunic, Inc. | 106.29M | -4.06% | 218,938 | - |
| 347 | VYGR | Voyager Therapeutics, Inc. | 105.79M | -3.41% | 1,392,083 | 25.11M |
| 348 | CDXS | Codexis, Inc. | 104.92M | -1.87% | 1,021,790 | 88.34M |
| 349 | EQ | Equillium, Inc. | 103.44M | -7.04% | 167,081 | 4.39M |
| 350 | CLLS | Cellectis S.A. | 102.52M | -3.62% | 42,647 | 63.82M |
| 351 | RTSN | Retension Pharmaceuticals, Inc. | 102.06M | 0.82% | 94,392 | - |
| 352 | UNCY | Unicycive Therapeutics, Inc. | 101.39M | -3.70% | 790,471 | - |
| 353 | NRXP | NRx Pharmaceuticals, Inc. | 98.64M | -6.56% | 604,514 | 3.39M |
| 354 | NBP | NovaBridge Biosciences | 96.28M | -3.60% | 710,643 | - |
| 355 | KZIA | Kazia Therapeutics Limited | 95.24M | -6.46% | 166,545 | 1.27M |
| 356 | PLYX | Polaryx Therapeutics, Inc. | 93.71M | -3.59% | 9,867 | - |
| 357 | ANIX | Anixa Biosciences, Inc. | 93.17M | -3.60% | 276,255 | - |
| 358 | ICCC | ImmuCell Corporation | 92.82M | 0.29% | 19,273 | 30.68M |
| 359 | HURA | TuHURA Biosciences, Inc. | 92.40M | -4.61% | 686,359 | - |
| 360 | MIST | Milestone Pharmaceuticals Inc. | 92.32M | -1.06% | 1,091,716 | 2.34M |
| 361 | AVXL | Anavex Life Sciences Corp. | 91.71M | -6.66% | 1,254,651 | - |
| 362 | PMVP | PMV Pharmaceuticals, Inc. | 91.37M | -3.97% | 353,447 | - |
| 363 | NKTX | Nkarta, Inc. | 90.71M | -14.53% | 1,026,300 | - |
| 364 | TVGN | Tevogen Inc. | 90.01M | -4.67% | 19,746 | - |
| 365 | VANI | Vivani Medical, Inc. | 88.71M | -12.97% | 1,390,848 | - |
| 366 | SEER | Seer, Inc. | 88.04M | 0.00% | 61,806 | 14.08M |
| 367 | BDTX | Black Diamond Therapeutics, Inc. | 87.35M | -5.59% | 956,139 | 70.00M |
| 368 | TENX | Tenax Therapeutics, Inc. | 86.31M | -4.73% | 741,556 | - |
| 369 | GNLX | Genelux Corporation | 85.14M | 1.06% | 137,305 | 8.00K |
| 370 | RLYB | Rallybio Corporation | 84.26M | -0.95% | 23,307 | 434.00K |
| 371 | CBUS | Cibus, Inc. | 83.31M | -6.03% | 160,802 | 4.35M |
| 372 | CHRS | Coherus Oncology, Inc. | 83.22M | -7.55% | 4,505,188 | 53.64M |
| 373 | NMRA | Neumora Therapeutics, Inc. | 81.36M | -8.46% | 854,227 | - |
| 374 | ATRA | Atara Biotherapeutics, Inc. | 79.60M | -3.65% | 16,692 | 3.97M |
| 375 | TNYA | Tenaya Therapeutics, Inc. | 79.21M | -6.38% | 2,241,663 | 3.03M |
| 376 | TLSA | Tiziana Life Sciences Ltd | 78.16M | -1.69% | 192,070 | - |
| 377 | COYA | Coya Therapeutics, Inc. | 76.71M | 1.87% | 141,124 | 4.69M |
| 378 | OKYO | OKYO Pharma Limited | 73.47M | -1.41% | 119,416 | - |
| 379 | RANI | Rani Therapeutics Holdings, Inc. | 73.21M | -7.54% | 704,022 | 6.58M |
| 380 | NTRB | Nutriband Inc. | 72.57M | 0.51% | 21,391 | 1.62M |
| 381 | NRXS | NeurAxis, Inc. | 72.21M | -4.64% | 178,698 | 6.53M |
| 382 | PDSB | PDS Biotechnology Corporation | 71.02M | -3.92% | 2,754,779 | - |
| 383 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 70.27M | -14.75% | 1,050,799 | - |
| 384 | MNOV | MediciNova, Inc. | 68.91M | -0.71% | 11,079 | 920.48K |
| 385 | GOSS | Gossamer Bio, Inc. | 68.75M | -3.85% | 188,926 | 78.42M |
| 386 | CNXU | Conexeu Sciences Inc. | 67.21M | -3.54% | 149,912 | - |
| 387 | FBIO | Fortress Biotech, Inc. | 66.37M | -1.00% | 297,958 | 68.47M |
| 388 | CING | Cingulate Inc. | 65.29M | -3.23% | 72,334 | - |
| 389 | CSBR | Champions Oncology, Inc. | 64.72M | -2.72% | 3,987 | 60.66M |
| 390 | CGTX | Cognition Therapeutics, Inc. | 64.31M | -0.15% | 348,266 | - |
| 391 | VRCA | Verrica Pharmaceuticals Inc. | 63.91M | -4.86% | 105,749 | 30.32M |
| 392 | TNXP | Tonix Pharmaceuticals Holding Corp. | 62.96M | -16.28% | 2,275,264 | 43.05M |
| 393 | ACRV | Acrivon Therapeutics, Inc. | 62.57M | -7.01% | 335,066 | - |
| 394 | HRTX | Heron Therapeutics, Inc. | 62.01M | -9.30% | 6,856,404 | 148.22M |
| 395 | MAIA | MAIA Biotechnology, Inc. | 61.43M | -1.94% | 273,734 | - |
| 396 | XBIT | XBiotech Inc. | 59.76M | 0.51% | 16,237 | - |
| 397 | SPRO | Spero Therapeutics, Inc. | 58.23M | -1.96% | 328,411 | 47.00M |
| 398 | CLNN | Clene Inc. | 57.60M | -4.65% | 108,859 | 238.00K |
| 399 | CRDF | Cardiff Oncology, Inc. | 56.60M | -4.93% | 314,452 | 508.00K |
| 400 | BOLD | Boundless Bio, Inc. | 55.96M | 0.00% | 33,586 | - |
| 401 | XLO | Xilio Therapeutics, Inc. | 54.22M | -2.72% | 8,936 | 55.01M |
| 402 | AZR | Azora Therapeutics, Inc. | 53.27M | 6.55% | 50,812 | - |
| 403 | NORD | Nordicus Partners Corporation | 52.66M | -9.70% | 822 | - |
| 404 | ANVS | Annovis Bio, Inc. | 52.55M | -0.71% | 1,164,074 | - |
| 405 | RNXT | RenovoRx, Inc. | 52.35M | -4.92% | 466,455 | 2.78M |
| 406 | ELOX | Eloxx Pharmaceuticals, Inc. | 52.03M | -0.92% | 3,104 | - |
| 407 | ATNM | Actinium Pharmaceuticals, Inc. | 49.99M | 0.00% | 348,113 | 35.09M |
| 408 | IBIO | iBio, Inc. | 49.01M | -7.52% | 292,500 | 1.08M |
| 409 | MREO | Mereo BioPharma Group plc | 48.71M | -0.52% | 708,122 | 800.00K |
| 410 | INKT | MiNK Therapeutics, Inc. | 48.63M | -6.79% | 14,701 | - |
| 411 | RNTX | Rein Therapeutics Inc. | 48.31M | -7.59% | 348,756 | - |
| 412 | HOWL | Werewolf Therapeutics, Inc. | 47.63M | -0.90% | 166,874 | 21.00M |
| 413 | ONCY | Oncolytics Biotech Inc. | 47.43M | -9.62% | 817,513 | - |
| 414 | GANX | Gain Therapeutics, Inc. | 47.14M | -2.70% | 300,360 | - |
| 415 | HYFT | MindWalk Holdings Corp. | 47.11M | -2.91% | 221,042 | 11.57M |
| 416 | PLRX | Pliant Therapeutics, Inc. | 45.82M | -4.84% | 525,308 | - |
| 417 | ELTX | Elicio Therapeutics, Inc. | 44.16M | -4.29% | 232,784 | - |
| 418 | DWTX | Dogwood Therapeutics, Inc. | 42.82M | -5.08% | 119,600 | 100.00K |
| 419 | TIL | Instil Bio, Inc. | 42.32M | -1.11% | 98,140 | - |
| 420 | HYPD | Hyperion DeFi, Inc. | 42.27M | 0.37% | 159,977 | 1.40M |
| 421 | CNTB | Connect Biopharma Holdings Limited | 41.90M | -3.43% | 202,923 | 2.95M |
| 422 | CRBU | Caribou Biosciences, Inc. | 41.08M | -2.69% | 1,539,712 | 9.44M |
| 423 | BMEA | Biomea Fusion, Inc. | 40.79M | -7.89% | 839,006 | - |
| 424 | IBO | Impact BioMedical Inc. | 40.75M | 10.93% | 7,226 | 38.00K |
| 425 | IRLA | IRulya Therapeutics Inc. | 40.46M | 3.78% | 138,118 | - |
| 426 | KLRS | Kalaris Therapeutics, Inc. | 39.52M | -12.63% | 200,281 | - |
| 427 | IMA | ImageneBio, Inc. | 39.16M | -7.26% | 10,745 | 800.00K |
| 428 | ALPS | Alps Group Inc | 39.10M | -1.26% | 38,792 | 3.74M |
| 429 | GRDX | GridAI Technologies Corp. | 38.38M | -2.34% | 59,812 | - |
| 430 | GRCE | Grace Therapeutics, Inc. | 38.08M | -2.43% | 82,349 | - |
| 431 | ALDX | Aldeyra Therapeutics, Inc. | 38.01M | -3.27% | 569,298 | - |
| 432 | APLM | Apollomics, Inc. | 37.99M | -6.99% | 10,498 | 413.00K |
| 433 | EXOZ | eXoZymes, Inc. | 37.13M | 0.00% | 10,878 | -700.00 |
| 434 | TELO | Telomir Pharmaceuticals, Inc. | 36.84M | -15.90% | 230,390 | - |
| 435 | VERU | Veru Inc. | 36.15M | -0.93% | 91,475 | 16.89M |
| 436 | SER | Serina Therapeutics, Inc. | 35.81M | -6.00% | 28,416 | 130.00K |
| 437 | ATHE | Alterity Therapeutics Limited | 35.37M | -9.31% | 71,552 | 2.50M |
| 438 | LONA | LeonaBio, Inc. | 35.14M | -3.87% | 25,480 | - |
| 439 | OSTX | OS Therapies Incorporated | 34.66M | -14.00% | 1,339,568 | - |
| 440 | NNVC | NanoViricides, Inc. | 34.46M | -2.17% | 154,068 | - |
| 441 | AARD | Aardvark Therapeutics, Inc. | 33.26M | -4.40% | 249,783 | - |
| 442 | INMB | INmune Bio Inc. | 32.29M | -4.55% | 410,234 | 50.00K |
| 443 | ACET | Adicet Bio, Inc. | 31.54M | -2.01% | 371,393 | - |
| 444 | PMN | ProMIS Neurosciences, Inc. | 31.21M | -7.45% | 127,606 | - |
| 445 | PTHS | Pelthos Therapeutics Inc. | 30.74M | -14.48% | 127,990 | 43.30M |
| 446 | BCTX | BriaCell Therapeutics Corp. | 30.45M | -2.23% | 44,625 | - |
| 447 | NXTC | NextCure, Inc. | 28.52M | 4.18% | 43,034 | - |
| 448 | EDSA | Edesa Biotech, Inc. | 28.10M | -6.31% | 505,086 | - |
| 449 | PLRZ | Polyrizon Ltd. | 27.88M | 4.20% | 19,652 | - |
| 450 | CRVO | CervoMed Inc. | 27.69M | 3.39% | 3,198,465 | 8.73K |
| 451 | LITS | Lite Strategy, Inc. | 27.58M | -7.94% | 258,196 | - |
| 452 | EYPT | EyePoint, Inc. | 27.54M | -10.40% | 5,815,175 | 2.58M |
| 453 | MGX | Metagenomi Therapeutics, Inc. | 26.97M | -5.59% | 182,231 | 7.09M |
| 454 | IMMP | Immutep Limited | 25.92M | 2.67% | 61,441 | 13.79M |
| 455 | ABVC | ABVC BioPharma, Inc. | 25.02M | -2.87% | 44,185 | 797.92K |
| 456 | BYSI | BeyondSpring Inc. | 24.71M | -6.65% | 47,884 | 1.88M |
| 457 | BSEM | BioStem Technologies, Inc. | 24.16M | -11.56% | 399,393 | 34.59M |
| 458 | RNAZ | TransCode Therapeutics, Inc. | 23.54M | -0.69% | 13,915 | - |
| 459 | EVAX | Evaxion A/S | 23.10M | -4.81% | 67,624 | 7.49M |
| 460 | ESLA | Estrella Immunopharma, Inc. | 22.57M | -34.64% | 1,574,519 | - |
| 461 | CELU | Celularity Inc. | 22.22M | -8.81% | 122,107 | 18.67M |
| 462 | FLNA | Filana Therapeutics, Inc. | 21.64M | -7.07% | 431,051 | - |
| 463 | CVM | CEL-SCI Corporation | 20.93M | -9.16% | 150,505 | - |
| 464 | ATOS | Atossa Therapeutics, Inc. | 19.36M | -4.43% | 91,433 | - |
| 465 | IGC | IGC Pharma, Inc. | 19.07M | -7.24% | 360,182 | 1.11M |
| 466 | COCP | Cocrystal Pharma, Inc. | 19.07M | -2.94% | 22,477 | 330.00K |
| 467 | CNTX | Context Therapeutics Inc. | 18.19M | -8.38% | 529,172 | - |
| 468 | QNRX | Quoin Pharmaceuticals, Ltd. | 18.02M | -0.27% | 5,538 | - |
| 469 | KTTA | Pasithea Therapeutics Corp. | 17.37M | -2.27% | 198,260 | - |
| 470 | ACTU | Actuate Therapeutics, Inc. | 16.28M | -2.05% | 155,900 | - |
| 471 | BIVI | BioVie Inc. | 16.03M | -5.56% | 161,914 | - |
| 472 | ABOS | Acumen Pharmaceuticals, Inc. | 15.77M | -5.22% | 885,783 | - |
| 473 | QNTM | Quantum BioPharma Ltd. | 15.60M | -8.25% | 278,764 | - |
| 474 | NCEL | NewcelX Ltd. | 15.54M | -3.93% | 12,168 | - |
| 475 | TVRD | Tvardi Therapeutics, Inc. | 15.41M | -13.81% | 167,021 | - |
| 476 | BOLT | Bolt Biotherapeutics, Inc. | 15.28M | -5.59% | 177,671 | 4.70M |
| 477 | ATYR | aTyr Pharma, Inc. | 15.23M | -8.27% | 35,142 | 190.00K |
| 478 | MRKR | Marker Therapeutics, Inc. | 15.01M | -5.27% | 140,799 | 3.55M |
| 479 | AKTX | Akari Therapeutics, Plc | 14.88M | -12.62% | 14,523 | - |
| 480 | JSPR | Jasper Therapeutics, Inc. | 14.83M | -9.42% | 32,382 | - |
| 481 | CTXR | Citius Pharmaceuticals, Inc. | 14.62M | 10.78% | 650,807 | 7.11M |
| 482 | ALLR | Allarity Therapeutics, Inc. | 14.54M | -2.30% | 78,066 | 345.00K |
| 483 | KYNB | Kyntra Bio, Inc. | 14.54M | -2.45% | 6,963 | 4.62M |
| 484 | MCRB | Seres Therapeutics, Inc. | 14.37M | -6.00% | 74,191 | 2.13M |
| 485 | NEUP | Neuphoria Therapeutics Inc. | 13.96M | -4.80% | 19,711 | 1.17M |
| 486 | PLUR | Pluri Inc. | 13.46M | -9.17% | 18,914 | 1.02M |
| 487 | LPCN | Lipocine Inc. | 13.36M | 1.89% | 93,608 | 3.74M |
| 488 | PASG | Passage Bio, Inc. | 12.90M | 0.25% | 12,472 | - |
| 489 | DYAI | Dyadic International, Inc. | 12.76M | -9.77% | 116,444 | 3.80M |
| 490 | DARE | Daré Bioscience, Inc. | 12.67M | -7.19% | 39,726 | 1.37M |
| 491 | BCDA | BioCardia, Inc. | 12.50M | -10.38% | 288,131 | 3.00K |
| 492 | ALGS | Aligos Therapeutics, Inc. | 12.36M | -8.33% | 120,510 | 33.65M |
| 493 | RADX | Radiopharm Theranostics Limited | 11.81M | -3.66% | 32,968 | 8.90M |
| 494 | PBM | Psyence Biomedical Ltd. | 11.79M | -2.83% | 66,043 | - |
| 495 | LSTA | Lisata Therapeutics, Inc. | 11.53M | 6.67% | 119,688 | 100.00K |
| 496 | PTN | Palatin Technologies, Inc. | 11.48M | -4.23% | 13,486 | 13.19M |
| 497 | HIND | Vyome Holdings, Inc. | 11.44M | 3.82% | 6,461 | 129.73K |
| 498 | TCRX | TScan Therapeutics, Inc. | 11.39M | -9.48% | 714,485 | 7.11M |
| 499 | CLRB | Cellectar Biosciences, Inc. | 10.96M | -4.13% | 50,906 | - |
| 500 | GUTS | Fractyl Health, Inc. | 10.77M | -7.84% | 174,782 | 3.00K |